Livnat Jerby is an Assistant Professor in the Department of Genetics at Stanford University. Her research focuses on multicellular circuits as a disease driver and therapeutic avenue, aiming to develop tissue remodeling and immunomodulating interventions for disease treatment and prevention. As a postdoctoral fellow in Aviv Regev’s lab at the Broad Institute of MIT and Harvard, she identified novel regulators of T cell exclusion and dysfunction. Her work identified new mechanisms controlling cellular and tissue immunogenicity and demonstrated the potential of epigenetic reprogramming as a therapeutic modality to overcome immunotherapy resistance in cancer. Dr. Jerby holds a B.Sc. in Computer Science and Biology and obtained her Ph.D. in 2016 from Tel Aviv University, where she worked with Prof. Eytan Ruppin, studying non-linear genetic interactions. In November 2020 she joined Stanford Genetics to establish her own lab. Bringing together latest advances in single-cell genomics, imaging, genetic engineering, and machine learning, her laboratory develops scalable systems to study and reprogram multicellular circuits at greater scale, resolution, and depth. Her research has been generously supported by the Rothschild Foundation, the Schmidt Family Foundation, the Cancer Research Institute (CRI), the Burroughs Wellcome Fund (BWF), and Chan Zuckerberg Biohub initiative.